BackEvogene Overview

Evogene Current Cash

Evogene's current cash is $8.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.54M
13.98% YoYΔ $1.05M vs prior year quarter

Peer average

Loading

Evogene Current Cash History

Loading

Evogene vs. peers: Current Cash Comparison

Loading

Evogene Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evogene (EVGN) FAQ

As of the most recent data (March 2026), EVGN shows a current cash of $8.5M. That compares with $7.5M in the prior-year period — up 14.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EVGN's current cash is now $8.5M (was $7.5M) — a 14.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Evogene is outperforming or lagging.

Tracking EVGN's current cash over time shows whether Evogene is scaling, shrinking, or reshaping that part of the business. The current reading is $8.5M That compares with $7.5M in the prior-year period — up 14.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Evogene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $8.5M) with ownership activity and broader fundamentals.

Evogene's current cash is $8.5M; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.